Shionogi & Co Ltd: Submits New Drug Application in Japan for Zuranolone as a Treatment for Major Depressive Disorder
日本藥廠塞諾基公司:提交新藥申請,將左拉諾隆用作治療重性抑鬱症。
Shionogi & Co Ltd: Submits New Drug Application in Japan for Zuranolone as a Treatment for Major Depressive Disorder
日本藥廠塞諾基公司:提交新藥申請,將左拉諾隆用作治療重性抑鬱症。
譯文內容由第三人軟體翻譯。